Trial intelligence / Profile preview

Effect of Montelukast on Sputum MMPs in Asthma

NCT00947453Phase 2Completed

Sponsor
University of East Anglia
Start
Jul 2009
Primary completion
Dec 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in asthma comparing Montelukast Group with Placebo Group (2 arms). Primary endpoint: MMP and TIMP mRNA profile relative to a housekeeping gene at 8 weeks. Started Jul 2009; status: completed.

02

Drugs

montelukast
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00947453.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00947453.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call